Month: <span>March 2025</span>
Month: March 2025

Associations Between Exercise Training, Physical Activity, Sedentary Behaviour and Mortality: An Umbrella Review of Meta-Analyses

J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13772. doi: 10.1002/jcsm.13772. ABSTRACT BACKGROUND: Numerous studies support the association of exercise training, physical activity (PA) and sedentary behaviour (SB) …

Early adolescence assessment of eleven boys treated with continuous subcutaneous infusion (CSGI) of recombinant LH and FSH during infancy

Endocr Connect. 2025 Feb 1:EC-24-0082. doi: 10.1530/EC-24-0082. Online ahead of print. ABSTRACT INTRODUCTION: We previously observed that continuous subcutaneous gonadotropin infusion (CSGI) in infants with …

Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study

Pediatr Pulmonol. 2025 Mar;60(3):e71022. doi: 10.1002/ppul.71022. ABSTRACT OBJECTIVE: To compare the Respiratory Syncytial Virus (RSV) hospitalization burden among 29-34 weeks gestational age (wGA) preterm infants …

Nanoscale distribution of bioactive ligands on biomaterials regulates cell mechanosensing through translocation of actin into the nucleus

Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2501264122. doi: 10.1073/pnas.2501264122. Epub 2025 Mar 5. ABSTRACT Cells respond to adhesive ligands such as arginine-glycine-aspartate …

The association of childhood HDL cholesterol with atherosclerotic CVD events in adults: findings from the International Childhood Cardiovascular Cohort Consortium

Eur J Prev Cardiol. 2025 Mar 5:zwaf117. doi: 10.1093/eurjpc/zwaf117. Online ahead of print. ABSTRACT AIMS: The role of adult HDL-C in atherosclerotic cardiovascular disease (ASCVD) …

Valsartan and Cardiac Remodeling in Early-Stage Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial Cardiac Magnetic Resonance Substudy

JAMA Cardiol. 2025 Mar 5. doi: 10.1001/jamacardio.2024.5677. Online ahead of print. ABSTRACT IMPORTANCE: Valsartan has been shown to attenuate phenotypic progression among individuals with early-stage …

Sustained Clinical Remission of BRAF V600E-Mutated Langerhans Cell Histiocytosis With Multiorgan Involvement in an Infant Treated With Dabrafenib

J Pediatr Hematol Oncol. 2025 Mar 6. doi: 10.1097/MPH.0000000000003014. Online ahead of print. ABSTRACT BACKGROUND: Above 50% of LCH cases show BRAF-mutations, which can be …